Financials · Asset Management & Custody Banks · US stock · price as of 22 Oct 2026
Key indicators
Price
$496.83
52-week range
$422.37 – $572.56
Market cap
$46.2B
P/E (trailing)
12.1×
Dividend yield
1.3%
Revenue (last 12 months)
$19.8B
Revenue growth (3y a year)
9.7%
Price / book
7.3×
Return on equity
62.0%
Fair value
Fair value (average of valid models)$573.73 middle half of models $502 – $548
Versus priceFair+16% to fair value
P/E multiple
$501.73
P/B multiple
$518.21
P/S multiple
$547.83
Dividend discount, stable
$470.81
Dividend discount, multi-stage
$830.06
Model uncertainty
Medium
X-Ray Score
67/ 100 · Medium confidence · ahead of 96% of sector peers
Valuation84
Growth55
Profitability60
Financial health73
Dividends58
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Ameriprise Financial provides wealth management, asset management and insurance and annuity products. Its network of financial advisors serves individual clients with planning, investment accounts and retirement services, while its asset management arm offers funds and strategies under the Columbia Threadneedle name. The company earns fees tied to client assets and advice, plus spread and premium income from insurance and annuity products. Market levels therefore have a strong influence on its results.
Sales came to $19.8 billion in the last twelve months, having expanded at 9.7% a year across the last three years. Its operating margin came to 25.5%. The company pays a dividend, yielding 1.3%. These figures describe past results and say nothing certain about the future.
StocksXray gives Ameriprise Financial Inc an X-Ray Score of 67 out of 100 (medium confidence), ahead of 96% of the S&P 500 stocks in its sector. Its strongest lens is valuation (84) and its weakest is growth (55).
Our fair value (the average of the valid models) is $573.73 (range $501.73 to $547.83). At $496.83 the stock trades 13% below that value, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Ameriprise Financial Inc (AMP)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$281.49
$295.49
$366.38
$520.61
$485.60
$496.83
Market cap
$33.8B
$33.6B
$39.5B
$53.6B
$47.7B
$46.2B
P/E
9.9×
10.7×
15.5×
15.8×
13.4×
12.1×
Price / book
7.0×
8.8×
8.4×
10.2×
7.3×
7.3×
Dividend yield
–
–
–
–
–
1.33%
Fundamentals checklist ● 3 Good · ● 3 Average · ● 0 Bad · each check graded against the sector
Risk models
Piotroski F-Score8 of 9Good
Growth
EPS growth (3y)9.4%Average
Revenue growth (3y)9.7%Average
Growth consistency100%Good
Valuation
Fair value vs price1.2×Good
Profitability
Operating margin25.5%Average
XStocksXray
Ameriprise Financial Inc (AMP)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
13,389
14,334
16,096
17,926
18,911
19,839
Net income
3,417
3,149
2,556
3,401
3,563
3,948
Diluted EPS ($)
28.48
27.70
23.71
33.05
36.28
41.19
Net margin
25.5%
22.0%
15.9%
19.0%
18.8%
19.9%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
177,735
158,852
175,191
181,403
190,904
197,871
Cash
9,569
8,755
8,620
9,489
11,158
11,159
Total debt
–
–
–
–
–
–
Equity
4,837
3,803
4,729
5,228
6,549
6,366
Dividend per share ($)
–
–
–
–
–
–
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.
